The role of vaccine status homophily in the COVID-19 pandemic: a cross-sectional survey with modelling.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Connect Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      COVID-19*/epidemiology ; COVID-19*/prevention & control; Humans ; COVID-19 Vaccines ; Cross-Sectional Studies ; Pandemics/prevention & control ; Vaccination ; British Columbia/epidemiology
    • Abstract:
      Background: Vaccine homophily describes non-heterogeneous vaccine uptake within contact networks. This study was performed to determine observable patterns of vaccine homophily, as well as the impact of vaccine homophily on disease transmission within and between vaccination groups under conditions of high and low vaccine efficacy.
      Methods: Residents of British Columbia, Canada, aged ≥ 16 years, were recruited via online advertisements between February and March 2022, and provided information about vaccination status, perceived vaccination status of household and non-household contacts, compliance with COVID-19 prevention guidelines, and history of COVID-19. A deterministic mathematical model was used to assess transmission dynamics between vaccine status groups under conditions of high and low vaccine efficacy.
      Results: Vaccine homophily was observed among those with 0, 2, or 3 doses of the vaccine. Greater homophily was observed among those who had more doses of the vaccine (p < 0.0001). Those with fewer vaccine doses had larger contact networks (p < 0.0001), were more likely to report prior COVID-19 (p < 0.0001), and reported lower compliance with COVID-19 prevention guidelines (p < 0.0001). Mathematical modelling showed that vaccine homophily plays a considerable role in epidemic growth under conditions of high and low vaccine efficacy. Furthermore, vaccine homophily contributes to a high force of infection among unvaccinated individuals under conditions of high vaccine efficacy, as well as to an elevated force of infection from unvaccinated to suboptimally vaccinated individuals under conditions of low vaccine efficacy.
      Interpretation: The uneven uptake of COVID-19 vaccines and the nature of the contact network in the population play important roles in shaping COVID-19 transmission dynamics.
      (© 2024. The Author(s).)
    • References:
      J Prev Med Hyg. 2021 Jul 30;62(2):E311-E320. (PMID: 34604571)
      Vaccines (Basel). 2020 Dec 30;9(1):. (PMID: 33396832)
      Elife. 2021 Nov 25;10:. (PMID: 34821551)
      N Engl J Med. 2022 Apr 21;386(16):1532-1546. (PMID: 35249272)
      CMAJ. 2022 Dec 5;194(47):E1599-E1609. (PMID: 36507788)
      Acad Pediatr. 2021 May-Jun;21(4S):S24-S29. (PMID: 33958087)
      JMIR Public Health Surveill. 2016 Jul 29;2(2):e37. (PMID: 27473597)
      Infect Dis Poverty. 2021 Nov 14;10(1):132. (PMID: 34776011)
      Can Fam Physician. 2019 Mar;65(3):175-181. (PMID: 30867173)
      Annu Rev Public Health. 2021 Apr 1;42:175-191. (PMID: 33798403)
      Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21544-9. (PMID: 20007780)
      Lancet. 2022 Mar 5;399(10328):924-944. (PMID: 35202601)
      Lancet Glob Health. 2021 May;9(5):e598-e609. (PMID: 33705690)
      JAMA Netw Open. 2021 Aug 2;4(8):e2122240. (PMID: 34448865)
      Int J Environ Res Public Health. 2021 Jul 29;18(15):. (PMID: 34360345)
      BMJ Glob Health. 2021 Sep;6(9):. (PMID: 34593513)
      Curr Opin Pediatr. 2020 Feb;32(1):151-159. (PMID: 31790027)
      Trials. 2016 Jul 22;17:341. (PMID: 27450066)
      Prev Med Rep. 2021 Dec 16;25:101673. (PMID: 34934611)
      Vaccine. 2014 Apr 17;32(19):2150-9. (PMID: 24598724)
      Lancet. 2021 Mar 13;397(10278):1023-1034. (PMID: 33587887)
      Phys Rev E. 2022 May;105(5):L052301. (PMID: 35706197)
      Radiol Bras. 2020 Mar-Apr;53(2):V-VI. (PMID: 32336833)
      Clin Ther. 2017 Aug;39(8):1550-1562. (PMID: 28774498)
      JAMA Netw Open. 2020 Dec 1;3(12):e2031756. (PMID: 33315116)
      Nat Commun. 2023 Sep 6;14(1):5452. (PMID: 37673865)
      Int J Infect Dis. 2022 Jan;114:252-260. (PMID: 34800687)
      Nat Commun. 2023 Feb 10;14(1):740. (PMID: 36765050)
      Nat Med. 2023 Feb;29(2):358-365. (PMID: 36593393)
      CMAJ. 2022 Apr 25;194(16):E573-E580. (PMID: 35470204)
      Clin Infect Dis. 2021 Jun 15;72(12):e1146-e1153. (PMID: 33283240)
      PLoS One. 2021 Dec 2;16(12):e0260973. (PMID: 34855929)
      Am J Infect Control. 2022 Jul;50(7):735-742. (PMID: 35131349)
      Expert Rev Vaccines. 2018 Nov;17(11):989-1004. (PMID: 30359151)
      Vaccines (Basel). 2021 Jun 05;9(6):. (PMID: 34198885)
    • Contributed Indexing:
      Keywords: COVID-19; Contact network; Homophily; Mathematical model; Transmission; Vaccine
    • Accession Number:
      0 (COVID-19 Vaccines)
    • Publication Date:
      Date Created: 20240214 Date Completed: 20240216 Latest Revision: 20240217
    • Publication Date:
      20240217
    • Accession Number:
      PMC10868109
    • Accession Number:
      10.1186/s12889-024-17957-5
    • Accession Number:
      38355444